Redwood Investment Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-19,046
Closed -$914K 292
2021
Q3
$914K Hold
19,046
0.13% 225
2021
Q2
$798K Hold
19,046
0.13% 205
2021
Q1
$642K Buy
+19,046
New +$678K 0.12% 224
2020
Q1
Sell
-19,046
Closed -$551K 226
2019
Q4
$551K Buy
+19,046
New +$527K 0.14% 178
2018
Q1
Sell
-10,530
Closed -$283K 138
2017
Q4
$283K Buy
+10,530
New +$268K 0.12% 82

Other funds holding NVO

Redwood Investment Management's NVO Position: Q4 2021 in Review

Redwood Investment Management sold out of Novo Nordisk (NVO) in Q4 2021, closing a stake of 19,046 shares — an estimated $914K sold.

Redwood Investment Management first reported a position in NVO in Q4 2017 and held it in 5 quarters. The position peaked at $914K in Q3 2021. 887 funds tracked by Wall St. Rank hold NVO as of Q4 2021.

  • Redwood Investment Management reported no remaining Novo Nordisk position as of Q4 2021 after selling out during the quarter.
  • Redwood Investment Management sold 19,046 Novo Nordisk shares in Q4 2021, an estimated $914K.
  • Redwood Investment Management first reported a position in Novo Nordisk in Q4 2017 and held it in 5 quarters.
  • Redwood Investment Management's Novo Nordisk position peaked at $914K in Q3 2021.
  • 887 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2021.

Based on Redwood Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.